Howard Mayer
Director/Board Member at PEPGEN INC.
Profile
Dr. Howard Mayer, MD, is an Executive Vice President-Research & Development at Ipsen SA, an Independent Director at Entasis Therapeutics Holdings, Inc. and an Executive VP, Head-Research & Development at Ipsen Pharmaceuticals, Inc. He is on the Board of Directors at Adagio Therapeutics, Inc., Entasis Therapeutics Holdings, Inc. and Melmark Charitable Foundation. Dr. Mayer was previously employed as an Independent Director by Genocea Biosciences, Inc., a Chief Medical Officer, Senior VP, Head-R&D by Shire Plc, a Chief Medical Officer by EMD Serono, Inc., a Head-Clinical Development & Medical Affairs by Pfizer Inc., a Director-Infectious Diseases Clinical Research by Bristol Myers Squibb Co., and a Head-Rare Disease Business Unit, R&D by Takeda Pharmaceuticals U.S.A., Inc. He also served on the board at Autism Speaks, Inc. He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Albert Einstein College of Medicine, Inc..
Howard Mayer active positions
| Companies | Position | Start |
|---|---|---|
| PEPGEN INC. | Director/Board Member | 2023-11-14 |
Melmark Charitable Foundation
 Melmark Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Melmark Charitable Foundation manages and coordinates all fundraising efforts throughout the Melmark organization. | Director/Board Member | 2015-12-31 |
Autism Speaks, Inc.
 Autism Speaks, Inc. Miscellaneous Commercial ServicesCommercial Services Autism Speaks, Inc. is an organization dedicated to advocating for individuals with autism spectrum disorder and their families. The non-profit company is based in New York, NY. The company aims to increase understanding and acceptance of people with autism and advance research into better interventions for autism spectrum disorder and related conditions. The company was founded by Robert C. Wright and Keith Andrew Wargo has been the CEO of the company since 2021. | Director/Board Member | 2010-12-31 |
Ipsen Pharmaceuticals, Inc.
 Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Former positions of Howard Mayer
| Companies | Position | End |
|---|---|---|
| IPSEN | Chief Tech/Sci/R&D Officer | 2023-09-21 |
| Ipsen Biopharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | 2023-08-31 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 2022-06-30 |
| INVIVYD, INC. | Director/Board Member | 2022-06-23 |
| GENOCEA BIOSCIENCES, INC. | Director/Board Member | 2020-08-02 |
Training of Howard Mayer
| University of Pennsylvania | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| IPSEN | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| PEPGEN INC. | Health Technology |
| Private companies | 8 |
|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Autism Speaks, Inc.
Autism Speaks, Inc. Miscellaneous Commercial ServicesCommercial Services Autism Speaks, Inc. is an organization dedicated to advocating for individuals with autism spectrum disorder and their families. The non-profit company is based in New York, NY. The company aims to increase understanding and acceptance of people with autism and advance research into better interventions for autism spectrum disorder and related conditions. The company was founded by Robert C. Wright and Keith Andrew Wargo has been the CEO of the company since 2021. | Commercial Services |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Health Technology |
| Ipsen Biopharmaceuticals, Inc. | |
Melmark Charitable Foundation
Melmark Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Melmark Charitable Foundation manages and coordinates all fundraising efforts throughout the Melmark organization. | Miscellaneous |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Howard Mayer
